World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   501 records for 189 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02226120
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
25/08/2014
Not recruitingNCT02226627
Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrici├│n y Salud
22/08/2014
Not recruitingNCT02155517
Phase 3 Clinical Evaluation of Two Pharmacokinetics Models of Propofol
19/05/2014
AuthorisedEUCTR2013-002076-41-BE
Study to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-002076-41-ATStudy to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation 14/04/2014
AuthorisedEUCTR2013-002076-41-ESStudy to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation11/04/2014
AuthorisedEUCTR2013-002076-41-HUStudy to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation 18/04/2014
Not recruitingNCT02181413A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant27/06/2014
AuthorisedEUCTR2013-002076-41-PLStudy to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation 10/06/2014
AuthorisedEUCTR2013-002076-41-NLStudy to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation 29/04/2014
AuthorisedEUCTR2013-002076-41-NOStudy to determine whether ixazomib citrate (MLN9708) as maintenance therapy has an effect on progression free survival and overall survival compared to placebo in patients with newly diagnosed multiple myeloma who have received induction therapy followed by high-dose therapy and autologous stem-cell transplantation 02/09/2014
09/04/2014
RecruitingNCT02092818
EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
19/03/2014
Not recruitingNCT02081183
A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis
05/03/2014
RecruitingNCT02059941
Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines
07/02/2014
Not recruitingNCT02048514
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
27/01/2014
RecruitingNCT02042144
Safety and Effectiveness of Regorafenib
20/01/2014
RecruitingNCT02011334
A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.
04/12/2013
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history